Savannah Resources Plc, the developer of the Barroso Lithium Project in Portugal, a ‘Strategic Project’ under the European Critical Raw Materials Act
The executive order (EO) of December 18 to reclassify cannabis to Schedule III is a monumental decision that will fundamentally reshape the
Best-to-date titanium–vanadium–iron drill results at Trapper Zone underscore Radar’s large-scale oxide system within the 160 km² Dykes River intrusive complex near tidewater
Blackrock Silver Corp. (TSXV: BRC,OTC:BKRRF) (OTCQX: BKRRF) (FSE: AHZ0) (‘Blackrock’ or the ‘Company’) is pleased to announce the completion of its non-brokered
Strategic Minerals plc (AIM: SML; USOTC: SMCDF), an international mineral exploration and production company, is pleased to provide the following update on
Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; ‘BRW’ or the ‘Company’) is very pleased to announce a maiden, open-pit Mineral Inferred Resource
Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (‘Skyharbour’ or the ‘Company’), is pleased to announce that it has acquired by low-cost staking
Homerun Resources Inc. (TSXV: HMR,OTC:HMRFF) (OTCQB: HMRFF) (‘Homerun’ or the ‘Company’) is pleased to inform that Brazil’s National Mining Agency (ANM) has issued on
(TheNewswire) Vancouver, Canada, January 8, 2026 TheNewswire – Spartan Metals Corp. (‘Spartan’ or the ‘Company’) (TSX-V: W | OTCQB: SPRMF |
(TheNewswire) January 8th, 2026 TheNewswire – Muskoka, Ontario Steadright Critical Minerals Inc. (CSE: SCM,OTC:SCMNF) (‘Steadright’ or the ‘Company’) is pleased to
HIGHLIGHTS: 2025 Production of 34,098 GEOs (32,990 gold ounces and 80,527 silver ounces) Cash balance of US$41M as of December 31, 2025 Heliostar Metals Ltd.
New Found Gold Corp. (TSXV: NFG) (NYSE American: NFGC) (‘New Found Gold’ or the ‘Company’) is pleased to highlight a transformational 2025 in which
The global lithium market weathered a tough 2025, as persistent oversupply and softer-than-expected electric vehicle demand pushed prices for the battery metal
The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device technology. In 2024 alone, 30
